Agilent to buy contract drug manufacturer Biovectra for $925 million

By Yahoo! Finance | Jul 22, 2024 at 03:52 PM EST

Agilent Technologies is acquiring Biovectra for $925 million to enhance its services for biotech companies. Biovectra provides services for drug manufacturers and specializes in active ingredients for complex drugs like GLP-1 weight loss drugs.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.